Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by 2031, Driven by Neurosurgical Advancements and Increasing Hydrocephalus Cases
[London, 25 November 2025] – Clearview Market Insights (CVMI) projects robust growth in the global cerebrospinal fluid (CSF) management market, with revenues rising from USD 2.43 billion in 2024 to USD 5.39 billion by 2031—a compound annual growth rate (CAGR) of 12.1%. The expansion is fueled by increasing rates of neurological disorders, a growing elderly population, and advancements in neurocritical care technologies.
Request Sample: https://clearviewmarketinsights.com/report-details/global-cerebrospinal-fluid-management-market/
“Modern CSF management solutions are revolutionizing approaches to hydrocephalus, traumatic brain injury, and intracranial hypertension,” notes Dr. Sophia Lindgren, neurodevices analyst at CVMI.
Key Market Highlights
· 2024 Market Size: USD 2.43 billion
· 2031 Forecast: USD 5.39 billion
· CAGR: 12.1% (2024–2031)
Growth Drivers
· Rising Incidence of Hydrocephalus: Particularly among aging individuals and pediatric patients
· Increase in Trauma and TBI Cases: Driving demand for intracranial pressure (ICP) management devices
· Technological Advancements: Emergence of programmable, antimicrobial, and AI-integrated shunt systems
Segment Insights
· Leading Product: Shunt systems, accounting for more than 65% of the market
· Highest Growth Segment: External drainage systems for critical care and ICP management
Regional Trends
· Market Leader: North America, followed by Europe
· Fastest-Growing Region: Asia-Pacific
Competitive Landscape (2024)
· Medtronic: 27% market share, renowned for programmable shunt technology
· Integra: 22% share, strong in drainage systems and valves
· B. Braun: 16% share, specialization in advanced CSF drainage
· Others: 35%, comprising regional and niche OEMs
Future Outlook to 2031
Growth in the CSF management sector will be driven by developments in wireless intracranial pressure monitoring, antimicrobial materials, and AI-powered clinical support. Market expansion is expected to accelerate, particularly in emerging economies, as neurosurgical care continues to evolve and improve.
For detailed insights or media inquiries - https://clearviewmarketinsights.com/
contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
